Rituximab + immunotherapy in follicular lymphoma
Condition: Follicular Lymphoma Interventions: Drug: Rituximab; Drug: Utomilumab; Drug: Avelumab; Drug: PF04518600 Sponsors: Dana-Farber Cancer Institute; Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials